A B7H3-targeting antibody–drug conjugate in advanced solid tumors: a phase 1/1b trialYuxiang Ma, Hongyun Zhao, Jinhui Xue et al.|Nature Medicine|2025Cited by 76
Abstract A081: Resistance Mechanisms to Monotherapy RAS(ON) Multi-Selective Inhibitor Daraxonrasib (RMC-6236) in RAS Mutant PDAC Inform Therapeutic Combination StrategiesIda Aronchik, Mallika Singh, Sumit Kar et al.|Molecular Cancer Therapeutics|2025Cited by 1